ArticleHeliyon2024

Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease.

Giorgio Turconi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.